• Profile
Close

Risk markers for significant bleeding and thrombosis in pediatric acute promyelocytic leukemia; Report from the Children’s Oncology Group Study AAML0631

Journal of Pediatric Hematology/Oncology Dec 21, 2018

Rajpurkar M, et al. - Given that acute promyelocytic leukemia (APL) is characterized by an increased risk of coagulopathy with significant morbidity and mortality, researchers reported the evaluation of presenting white blood cell (WBC) and the International Society on Thrombosis and Haemostasis (ISTH) disseminated intravascular coagulation (DIC) scoring system as markers for early death and nonlethal coagulopathy in pediatric APL. For this investigation, 79 pediatric patients treated on a Children’s Oncology Group phase III clinical trial were evaluated. Findings suggested a significant association of elevated presenting WBC with early death but not with both lethal and nonlethal coagulopathy events. An ISTH DIC score of ≥5 was not correlated with either early deaths or coagulopathy events. However, an ISTH DIC score threshold of 6 was significantly related to early death and with both lethal and nonlethal coagulopathy events. The presenting WBC is a marker for risk of early death in pediatric APL patients. Other biomarkers that can predict APL-related coagulopathy need to be identified strongly.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay